Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To the Investigators' knowledge, TXA has not been studied in the setting of reverse total
shoulder arthroplasty. We propose a double-blinded, randomized, controlled trial comparing
perioperative administration of TXA to placebo in the setting of RTSA. The purpose of this
study is to examine the efficacy of TXA in reducing overall blood loss and transfusion rates
in patients undergoing reverse total shoulder arthroplasty.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
William Beaumont Hospitals
Treatments:
Antifibrinolytic Agents Molecular Mechanisms of Pharmacological Action Tranexamic Acid